Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableActive Not RecruitingNCT07348718
What this trial is testing

Rubix LS Diabetic Kidney Disease (DKD) Registry Study

Who this might be right for
Diabetic Kidney Disease (DKD)
Rubix LS 2,000
Post-approval studies (Phase 4)Study completedNCT01588795
What this trial is testing

Renal Denervation in Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyPersistent Proteinuria With Type II Diabetes
Assistance Publique - Hôpitaux de Paris 25
Large-scale testing (Phase 3)Study completedNCT00141453
What this trial is testing

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Who this might be right for
Diabetic NephropathyType 2 Diabetes MellitusProteinuria
Daiichi Sankyo Co., Ltd. 577
Not applicableLooking for participantsNCT04916132
What this trial is testing

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Who this might be right for
Chronic Kidney DiseasesAlbuminuriaDiabetic Kidney Disease+4 more
Herlev Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01356849
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 149
Not applicableUnknownNCT01566006
What this trial is testing

Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
The Nazareth Hospital, Israel 80
Large-scale testing (Phase 3)Study completedNCT00552409
What this trial is testing

Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease

Who this might be right for
Diabetes MellitusChronic Kidney DiseaseDiabetic Kidney Disease
University of Washington 22
Not applicableUnknownNCT03445247
What this trial is testing

Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy Type 2
Chang Gung Memorial Hospital 60
Not applicableStudy completedNCT04006028
What this trial is testing

Kidney Biopsy Indications in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes, Chronic Kidney Disease
Rennes University Hospital 500
Large-scale testing (Phase 3)Study completedNCT00556465
What this trial is testing

Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyChronic Kidney DiseaseDiabetes Type 2
Shiraz University of Medical Sciences 60
Testing effectiveness (Phase 2)Study completedNCT00920764
What this trial is testing

Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 92
Testing effectiveness (Phase 2)Study completedNCT05570305
What this trial is testing

Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

Who this might be right for
Chronic Kidney Diseases
University Medical Center Groningen 42
Post-approval studies (Phase 4)UnknownNCT03502031
What this trial is testing

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

Who this might be right for
Renal Insufficiency, ChronicDiabetic Nephropathy Type 2
James A. Tumlin, MD 72
Not applicableStudy completedNCT00364988
What this trial is testing

Pioglitazone and Losartan Provides Additional Renoprotection

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Early research (Phase 1)Study completedNCT01464320
What this trial is testing

Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

Who this might be right for
Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine
Abbott 16